Publications:

Inhibition of HECT E3 ligases as potential therapy for COVID-19.

Cell Death & Disease

Novelli, Giuseppe G; Liu, Jing J; Biancolella, Michela M; Alonzi, Tonino T; Novelli, Antonio A; Patten, J J JJ; Cocciadiferro, Dario D; Agolini, Emanuele E; Colona, Vito Luigi VL; Rizzacasa, Barbara B; Giannini, Rosalinda R; Bigio, Benedetta B; Goletti, Delia D; Capobianchi, Maria Rosaria MR; Grelli, Sandro S; Mann, Justin J; McKee, Trevor D TD; Cheng, Ke K; Amanat, Fatima F; Krammer, Florian F; Guarracino, Andrea A; Pepe, Gerardo G; Tomino, Carlo C; Tandjaoui-Lambiotte, Yacine Y; Uzunhan, Yurdagul Y; Tubiana, Sarah S; Ghosn, Jade J; , ; , ; , ; Notarangelo, Luigi D LD; Su, Helen C HC; Abel, Laurent L; Cobat, Aurélie A; Elhanan, Gai G; Grzymski, Joseph J JJ; Latini, Andrea A; Sidhu, Sachdev S SS; Jain, Suresh S; Davey, Robert A RA; Casanova, Jean-Laurent JL; Wei, Wenyi W; Pandolfi, Pier Paolo PP

Publication Date: 2021-03-24

Variant appearance in text: PI3K: G451A

PubMed Link: 33762578

Variant Present in the following documents:

• 41419_2021_Article_3513.pdf

View BVdb publication page